Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	54.04	43.05	65.47	112.35	4.21	3.22
Short-Term Investments	35.34	24.69	17.38	-	-	-
Cash & Short-Term Investments	89.38	67.74	82.85	112.35	4.21	3.22
Cash Growth	7.13%	-18.24%	-26.26%	2566.65%	30.96%	-85.15%
Accounts Receivable	5.49	16.12	7.19	1.42	2.44	1.68
Other Receivables	2.3	1.26	1.11	0.11	0.14	0.18
Receivables	7.79	17.38	8.3	1.53	2.58	1.87
Prepaid Expenses	2.28	1.82	1.69	0.89	0.66	0.48
Restricted Cash	-	-	-	-	0.11	0.34
Other Current Assets	-	-	-	0.29	0.83	1.07
Total Current Assets	99.44	86.94	92.83	115.06	8.38	6.97
Property, Plant & Equipment	1.43	1.53	1.78	2.03	2.39	3.01
Long-Term Investments	6.11	-	20	15.42	-	-
Goodwill	4.7	4.7	-	-	-	-
Other Intangible Assets	70.61	69.23	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-	0.4	0.4
Other Long-Term Assets	9.27	9.94	0.72	0.44	0.04	0.13
Total Assets	191.55	172.33	115.34	132.94	11.21	10.51
Accounts Payable	24.46	13.99	3.61	0.52	1.17	1.14
Accrued Expenses	8.55	18.97	7.21	2.52	5.47	3.77
Short-Term Debt	-	37.7	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.39	-
Current Portion of Leases	0.54	0.54	0.49	0.37	0.5	0.52
Other Current Liabilities	0.93	2.52	0.71	0.82	-	-
Total Current Liabilities	34.48	73.72	12.02	4.23	7.54	5.43
Long-Term Debt	58.9	5.07	12.8	-	68.05	77.34
Long-Term Leases	0.48	0.46	0.84	1.24	1.61	2.07
Other Long-Term Liabilities	27.91	31.22	14.55	0.36	0.43	0.12
Total Liabilities	121.78	110.46	40.22	5.82	77.62	84.96
Common Stock	0.01	0	0	0	-	-
Additional Paid-In Capital	550.41	472.66	436.27	396.96	192.06	171.26
Retained Earnings	-469.55	-399.78	-353.73	-267.03	-258.47	-245.71
Treasury Stock	-10.98	-10.98	-7.54	-2.81	-	-
Comprehensive Income & Other	-0.12	-0.04	0.11	-	-	-
Total Common Equity	69.77	61.86	75.12	127.12	-66.41	-74.46
Shareholders' Equity	69.77	61.86	75.12	127.12	-66.41	-74.46
Total Liabilities & Equity	191.55	172.33	115.34	132.94	11.21	10.51
Total Debt	59.93	43.77	14.13	1.61	70.55	79.93
Net Cash (Debt)	29.45	23.97	68.72	110.74	-66.33	-76.72
Net Cash Growth	-23.71%	-65.12%	-37.94%	-	-	-
Net Cash Per Share	0.69	0.68	1.99	3.72	-16.66	-41.39
Filing Date Shares Outstanding	53.38	41.85	34.54	34.42	28.38	3.17
Total Common Shares Outstanding	53.23	41.53	34.54	35.01	4.54	2.27
Working Capital	64.96	13.22	80.81	110.83	0.85	1.54
Book Value Per Share	1.31	1.49	2.17	3.63	-14.64	-32.77
Tangible Book Value	-5.54	-12.06	75.12	127.12	-66.41	-74.46
Tangible Book Value Per Share	-0.10	-0.29	2.17	3.63	-14.64	-32.77
Machinery	-	1.51	1.28	1.05	1.01	1.06
Leasehold Improvements	-	0.71	0.71	0.72	0.72	0.96

Source: S&P Capital IQ. Standard template. Financial Sources.